# DIHYDROERGOTAMINE MESYLATE
> **ANDA212907** · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA · Approved 2020-05-20
## Drug
- **FDA Application Number:** ANDA212907
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DIHYDROERGOTAMINE MESYLATE
- **Generic name:** DIHYDROERGOTAMINE MESYLATE NASAL
- **Active ingredients:** DIHYDROERGOTAMINE MESYLATE
- **Dosage form:** SPRAY, METERED
- **Route:** NASAL
- **Marketing status:** Prescription
- **Sponsor:** CIPLA
- **Manufacturer:** Cipla USA Inc.
- **First approval:** 2020-05-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212907)
---
*MORVS · CC0 1.0*